Influence of baseline airway calibre and pulmonary emphysema on bronchial responsiveness in patients with chronic obstructive pulmonary disease  by Koyama, H. et al.
Respiratory Medicine (1996) 90, 323-328 
Original Articles 
Influence of baseline airway calibre and pulmonary 
emphysema on bronchial responsiveness in patients 
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Chest Disease Research Institute, Kyoto University, Kyoto, Japan 
Study objective: Bronchial hyper-responsiveness (BHR) is widely observed in patients with chronic obstruc- 
tive pulmonary disease (COPD). However, its clinical significance in COPD has not yet been established. To 
determine the factors that influence BHR in COPD, multiple linear regression analysis was used to analyse the 
relationship between BHR to methacholine and baseline forced expiratory volume in 1 s (FEV,), vital capacity 
(VC), residual volume (RV)/total lung capacity (TLC), static compliance (Cst), transfer coefficient of the lung 
(Kco), and the percentage of low attenuation area (%LAA) determined by computed tomographic (CT) scan. 
Methods: Bronchial responsiveness to methacholine was determined in 63 patients with COPD by the 
dosimeter method and expressed as PD,,FEV,. Residual volume and TLC were determined by body 
plethysmography. The percentage of low attenuation area was defined as the percentage of area less than 
- 960 Hounsfield unit on a CT scan of the thorax. Results: Forced expiratory volume in 1s (%predicted) and 
%LAA correlated with BHR (P=O.O23 and 0.020, respectively), while VC (%pred), RV/TLC, Cst and Kco did 
not. The coefficient of determination was 0.43. The regression analysis showed that a 10% increase in 
FEV, (%pred) and a 10% decrease in %LAA would increase log(PD,,FEV,) by 0.145 and 0.117, respectively. 
Conclusions: A considerable proportion of the BHR in COPD is related to functional abnormalities and 
morphologic changes of emphysema, such as decreased baseline airway calibre and destruction of the lung 
parenchyma. 
Introduction 
Bronchial hyper-responsiveness (BHR) to non- 
specific stimuli is widely observed in patients with 
chronic obstructive pulmonary disease (COPD). The 
baseline airway calibre is known to be related to the 
degree of bronchial responsiveness to methacholine 
or histamine in patients with COPD (1,2). However, 
even after adjusting for the baseline level of lung 
function, BHR is still related to the accelerated 
annual decline of the forced expiratory volume in 1 s 
(FEV,) (3,4). Therefore, other factors must influence 
both bronchial responsiveness and the prognosis of 
COPD. Inflammation could increase bronchial 
responsiveness through mediator-induced hyper- 
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trophy or hyperplasia of the airway smooth muscle, 
which causes greater shortening of smooth muscles 
(5). Inflammation could cause oedema and fibrosis, 
which would thicken the airway wall, and it could 
also increase the epithelial permeability to non- 
specific stimuli, which would increase bronchial 
responsiveness (5). However, bronchial responsive- 
ness to non-specific stimuli in some patients with 
COPD is hardly affected by treatment with corticos- 
teroids, suggesting that inflammation is not a major 
cause of increased bronchial responsiveness in those 
patients. 
The loss of elastic recoil in COPD is believed to 
cause greater airway smooth muscle shortening by 
reducing the afterload, and thus increasing bronchial 
reactivity to non-specific stimuli (6). Elastic loading 
has also been reported to alter the mechanical 
properties of porcine trachealis muscle in vitro (7). In 
addition, Wiggs et al. have shown, by a simulation 
using the human tracheobronchial tree, that a loss of 
0 1996 W. B. Saunders Company Ltd 
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lung recoil can increase airway responsiveness in 
combination with airway wall thickening (8). 
Destruction of lung parencyma in emphysema may 
cause loss of lung recoil around small airways, and 
this destruction may be reflected functionally by 
decreased diffusion capacity or increased compliance, 
and morphologically by low attenuation areas on 
computed CT scan. 
To elucidate the effects of the functional and 
morphologic alterations of pulmonary emphysema 
on BHR in COPD, multiple regression analysis was 
used to determine the association of FEV,, vital 
capacity (VC), the lung volumes, mechanics and the 
extent of morphologic lung parenchymal destruc- 
tion with the degree of bronchial responsiveness to 
methacholine. 
Patients and Methods 
PATIENTS 
The study population consisted of 63 patients with 
COPD, who visited the Chest Disease Research Insti- 
tute Hospital of Kyoto University from 1987 to 1993 
with exertional dyspnoea and/or cough with sputum. 
The diagnosis of COPD was based on the definition 
provided by the American Thoracic Society (9). 
Patients with COPD in the present study fulfilled the 
following criteria: 
(1) 
(2) 
(3) 
A maximum FEV,/VC of less than 70% and 
a maximum FEV, of less than 100% of the 
predicted value over several measurements of 
postbronchodilator spirometry; 
A smoking history of greater than 20 pack-years; 
and 
No history consistent with asthma such as 
paroxysmal dyspnoea and wheezing. 
All patients were stable for at least 2 months 
prior to performing the baseline pulmonary function 
tests and the methacholine inhalation challenge test. 
Inhalation of P-receptor agonists or anti-cholinergic 
drugs was withheld for at least 12 h and oral theo- 
phylline for 48 h before the methacholine inhalation 
challenge and pulmonary function tests. None of 
the subjects had taken oral or inhaled steroids. 
The pulmonary function tests, including body 
plethysmography, methacholine inhalation challenge 
and CT scanning, were performed as part of the 
routine initial assessment of patients with COPD. 
Informed consent was obtained from all patients. 
METHODS 
Methacholine inhalation challenge 
Methacholine challenge tests were performed 
in patients who had an FEV, of more than 0.8 1, 
using the method described by Chai et al. (10). 
Methacholine chloride was dissolved in phosphate- 
buffered saline (pH 7.0). Phosphate-buffered saline 
(PBS) and methacholine solutions were delivered by a 
dosimeter (Rosenthal French, Baltimore, U.S.A.) 
using a No. 646 DeVilbiss nebulizer (DeVilbiss Co., 
Somerset, U.S.A.) at a pressure of 138 kPa (20 psi). 
Subjects performed spirometry correctly on a heated 
spirometer (AS-600, Minato Medical Equip. Co. 
Tokyo, Japan), three times before inhalation of PBS 
and twice after inhalation of PBS and each concen- 
tration of methacholine. The largest value for each 
series of measurement was used, and the dosage of 
methacholine required to produce a 20% fall in FEV, 
(PD,,FEV,) was calculated by linear interpolation 
of the log-cumulative dose-response curve. When 
inhalation of the maximum concentration of 
methacholine (25 mg dl - ‘) did not produce a fall in 
FEV, of more than or equal to 20%, the case was 
excluded from this study. The doses of methacholine 
were expressed as cumulative units (c.u.), where 
one inhalation of lmg ml-’ methacholine 
solution= 1 C.U. 
Pulmonary function tests 
Diffusion was measured by the single-breath 
method using carbon monoxide (11) (Chestax 65VH, 
Chest Co, Tokyo, Japan). The total lung capacity 
(TLC) was calculated as the sum of the volume of 
thoracic gas, as determined by pressure-corrected 
flow type body plethysmography (12) (model MBR 
2000M, Nihon Kohden Co., Tokyo, Japan), plus the 
inspiratory capacity. The residual volume (RV) was 
calculated as the thoracic gas volume minus the 
expiratory reserve volume. Static compliance was 
measured by the single-breath interrupted technique 
(13). A pressure-volume curve was obtained from the 
simultaneous recordings of oesophageal pressure 
minus mouth pressure and expired volume, during a 
single slow expiration through a valve that period- 
ically blocks the expired flow momentarily. The static 
compliance was calculated as the change in volume 
per change in pressure over the region of the 
pressure-volume curve between FRC and the FRC 
plus 0.5 1. The predicted values for the FEV, and VC 
were those established by the Japan Society of Chest 
Diseases (14). 
Cowputed tomography 
Computed tomographic scans were performed 
with a GE CT/T8800 (General Electric, Milwaukee, 
U.S.A.) scanner using 5-mm collimation, while 
patients held their breath after deep inspiration. 
Contrast medium was not injected. The scan field of 
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view was medium (35 cm), and the image data from 
the CT scan were taken from a 320 x 320 matrix. 
Thus, the size of each pixel was 1.1 x 1.1 mm. The 
standard reconstruction algorithm was used. Using a 
postero-anterior image of the thorax, three sections 
from each patient were selected for analysis: 1 cm 
above the upper margin of the aortic arch; 1 cm 
below the carina; and the widest area of the heart. 
The lung parenchyma was automatically differenti- 
ated from the chest wall and structures outside the 
body surface. The recognition of the lungs was 
confirmed by visual comparison with the CT scan. To 
assess the extent of emphysematous lesions, %LAA 
[percentage of low attenuation area, defined as the 
percentage of area less than - 960 Hounsfield unit 
(HU)] was calculated as the mean value of the three 
sections. The cut-off level ( - 960 HU) between nor- 
mal lung attenuation area and low attenuation lung 
area was chosen to be one standard deviation below 
the mean attenuation of lungs as determined in the 
study described elsewhere (15). 
Data analysis 
Multiple regression analysis was performed to 
determine the association of the various variables in 
bronchial responsiveness to methacholine using the 
STATISTICAm package (StatSoft, Inc., Oklahoma, 
U.S.A.). 
The static compliance (Cst), the transfer coeffi- 
cients of the lung (Kco) and the PD,,FEV, were 
log-transformed to normalize their distributions. The 
independent variables analysed were; FEV, (%pred), 
VC (%pred), log-transformed Cst, log-transformed 
Kco, TLC, RV/TLC ratio and %LAA. The volume- 
corrected diffusion capacity of the lung and the 
%LAA were selected as indices of lung parenchymal 
destruction, since both a decreased diffusion capacity 
(16,17) and low attenuation areas on CT scans 
(l&19) are known to correlate well with pathologic 
emphysema. The RV/TLC and the FEV,(%pred) 
were selected as indices for gas trapping and baseline 
airway calibre, respectively. Multiple linear regres- 
sion was obtained by the standard, forward and 
backward stepwise methods. 
Results 
Baseline pulmonary function tests and other 
characteristics of the patients in this study are 
summarized in Table 1. In one case, the maximum 
concentration of methacholine did not produce a fall 
in the FEV, greater than 20%, and that case was 
excluded from the present study. An average patient 
had moderate to moderately severe airflow limitation 
Table I Patient baseline characteristics 
Age (years) 
vc (1) 
%pred 
FEV,(l) 
%pred 
FEV,/FVC (%) 
TLC (1) 
%pred 
RW 
%pred 
RV/TLC (%) 
%LAA 
log(Kc0) 
Kco*T 
log(W) 
csty 
~~gP%,) 
PD,,*(c.u.) 
65.0 f 7.0 
3.47 zt 0.69 
97.6 f 16.1 
1.57 zt 0.46 
58.8 zk 16.2 
45.3 * 10.3 
7.80 * 1.49 
139.7 h 24.1 
4.33 f 1.31 
221.1 i 68.7 
54.8 zk 8.5 
45.2 dz 16.9 
0.0895 rt 0.1451 
1.23 (0.64-2.39) 
0.547 lk 0.194 
3.52 (1.02-11.02) 
1.0586 & 0.6608 
11.4 (0.30-225). 
Data were expressed as mean f SD. 
VC, vital capacity; FEV,, forced expiratory volume in 1 s; 
TLC, total lung capacity; RV, residual volume; Kco, trans- 
fer coefficient for the lung; Cst, static compliance; %LAA, 
percentage of low attenuation area; cu., cumulative units; 
*geometric mean (minimum-maximum); tmM min r 
kPa-’ 1-t; $1 kPa-‘. 
and an overinflated lung. Forty-nine of the 62 
patients (79.0%) had a PD,,FEV, for methacholine 
of less than 49.5 C.U. Nine individuals (14.5%) had an 
FEV, of 80-100% of the predicted value. Sixty-two 
patients whose PD,,FEV, was less than or equal 
to 225 C.U. were included in the multiple linear 
regression analysis. 
All three methods (standard, forward and 
backward stepwise) of multiple linear regression 
analysis showed a significant correlation between 
FEV,(%pred) and the %LAA with BHR. In contrast, 
VC (%predicted), RV/TLC, Cst and Kco did not 
correlate with BHR (Table 2). In the forward step- 
wise analysis, in which the adjusted R2 was the best 
among the three methods, the regression coefficients 
for each 10% increase in FEV, (%predicted) and 
the %LAA were 0.145 and - 0.117, respectively. In 
other words, each 10% increase in FEV, (%pred) and 
each 10% decrease in %LAA will increase the 
log(PD,,FEV,) by 0.145 and by 0.117, respectively. 
This means that a 20% increase in the FEV, (%pred) 
and 30% decrease in the %LAA will double the 
PD,,FEVr because log(2) = 0.301. 
The coefficient of multiple determination (R’) was 
0.43, which means that 43% of the original variability 
in the PD,,FEV, can be explained by the variables 
examined, whereas 57% remains residual variability. 
The correlation between the observed values for the 
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Table 2 Results of multiple linear regression analysis 
B SEOfP B SE of B t(w P-value 
Standard method 
Intercept 1.9482 
%LAA - 0.3329 0.1454 - 0.1302 
FEV, (%pred) 0.3595 0.1534 0.1466 
VC (%pred) - 0.1740 0.1550 - 0.07158 
Log(Kc0) - 0.06507 0.1409 - 0.2943 
Log(Cst) 0.2104 0.1214 0.6372 
RVITLC - 0.1850 0.1474 - 0.1446 
Rz0.66, R2=0.44. Adjusted R2=0.37, P<O.OOOOl 
Forward stepwise method 
Intercept 1.7972 
FEV, (%pred) 0.3563 0.1522 0.1453 
%LAA - 0.2997 0.1255 - 0.1172 
Log(W) 0.2246 0.1166 0.6802 
RV/TLC - 0.1849 0.1464 - 0.1446 
VC (%pred) - 0.1617 0.1516 - 0.06652 
R~0.66, R’zO.43, Adjusted R2=0.38, PiO.00000 
Backward stepwise method 
Intercept 0.5144 
%LAA - 0.3051 0.1070 - 0.1194 
FEV, (%pred) 0.4518 0.1070 0.1843 
Rz0.60, R2=0.36, Adjusted R’=O-34, WO.00000 
1.0905 1.7865 0.0795 
0.05688 - 2.2893 0.0259 
0.06258 2.3428 0.0228 
0.06375 - 1.1229 0.2664 
0.6374 - 0.4617 0.6462 
0.3675 1.7338 0.0886 
0.1152 - 1.2552 0.2147 
0.0330 1.7399 0.0874 
0.06208 2.3410 0.0228 
0.04910 - 2.3879 0.0203 
0.3530 1.9270 0.0591 
0.1144 - 1.2636 0.2116 
0.06236 - 1.0668 0.2906 
0.3604 1.4274 0.1587 
0.04187 - 2.8510 0.0060 
0.04365 4.2221 0~0001 
p, standardized regression coefficient, B, raw regression coefficients; VC, vital capacity; FEV,, 
forced expiratory volume in 1 s; TLC, total lung capacity; RV, residual volume; Cst, static 
compliance; %LAA, percentage of low attenuation area. Regression coefficients for each 10% in 
%LAA, FEV, (%pred), VC (%pred) and RV/TLC (%), for each 5 units in log(Cst) and 
log(Kc0). 
log-transformed PD,,FEV, and the predicted values ation was confirmed by linear regression analysis. 
from the multiple regression analysis is 
Fig. 1. 
When analysed separately by single 
analysis (Table 3), %LAA and log(Kco) 
with each other (Y= - 0.62, BO.001). 
Discussion 
Several studies have reported a correlation between 
bronchial responsiveness and symptoms (20,21), 
smoking status (20-22) atopic status (20,21), base- 
line airway calibre (20-23) and airway pathology (23) 
in various populations. However, the relationship 
between bronchial responsiveness and the func- 
tional and/or morphologic alterations caused by 
emphysema in patients with COPD has not been 
described adequately. 
shown in Geometric factors (24) and an increased deposition 
of bronchoconstrictor aerosols in the central airways 
regression (25) may contribute to this relationship. 
correlated Loss of lung recoil in COPD is believed to increase 
bronchial responsiveness by reducing the after-load of 
the airway smooth muscle (6). Lung parenchymal 
destruction in COPD is thought to cause loss of lung 
recoil. This destruction is likely reflected functionally 
by decreased diffusion capacity and increased com- 
pliance, and morphologically by low attenuation 
areas on CT scans. Thus, the authors hypothesized 
that these parameters are associated with bronchial 
responsiveness in COPD. This hypothesis also pre- 
dicts a relationship between the static compliance and 
bronchial responsiveness, which was not observed in 
this study. This result suggests that the static compli- 
ance does not reflect airway patency. Since most 
of the patients in this study had smoking-related 
centrilobular emphysema, which has been reported 
not to show the increase in static compliance typical 
It is well known that the baseline airway calibre 
correlates with bronchial responsiveness to non- 
specific stimuli in patients with COPD. This associ- 
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8 Predicted value of log-transformed PD,,,FEV, 
from multiple regression analysis 
Fig. 1 The correlation between observed values of log- 
transformed PD,,FEV, and the predicted values from 
multiple regression. 
of panlobular emphysema (26), the static compliance 
may not be relevant to the pathophysiologic altera- 
tions seen in this patient population. In addition, the 
static compliance was calculated from a region of the 
pressure-volume curve between FRC and FRC plus 
0.5 1; thus, the static compliance at this lung volume 
might not be appropriate for evaluating BHR, 
which was obtained from forced expiratory curves. 
Unfortunately, transpulmonary pressure at various 
lung volumes was not recorded. 
Both the decreased Kco and the low attenuation 
areas detected by CT scans are believed to reflect 
parenchymal destruction in patients within COPD. 
However, the %LAA correlated with bronchial 
responsiveness rather strongly, whereas the Kco did 
not, despite the fact that the %LAA and the log- 
transformed Kco correlated with each other very 
well. This finding may reflect a possible difference in 
the pathogenesis between low attenuation areas on a 
CT scan and decreased diffusion. In other words, a 
reduced diffusion capacity may reflect not only 
destruction of the ventilatory area, but also decreased 
pulmonary vasculature which may impair gas 
exchange, whereas the %LAA would not be 
influenced by such factors. Therefore, factors other 
than the destruction of the ventilatory area which 
influences diffusion capacity would not affect 
bronchial responsiveness. This may indicate that 
BHR is increased by alterations in the mechanical 
properties of the lung, which can be caused directly 
by the morphologic changes seen in emphysema, such 
as loss of elastic recoil of the lung parenchyma. 
The coefficient of determination in the present 
multiple linear regression analysis was 0.43, indicat- 
ing that the factors which were not examined in this 
study had significant effects on bronchial responsive- 
ness, For example, airway inflammation is regarded 
as an important factor in the pathogenesis of BHR in 
asthma (27,28), and chronic bronchiolar inflamma- 
tion associated with prolonged cigarette consumption 
is believed to contribute to the pathogenesis of BHR 
in COPD (5,23). However, these problems were not 
addressed in this study. 
In conclusion, it has been demonstrated that a 
considerable proportion of the bronchial responsive- 
ness observed in patients with COPD is related to 
functional abnormalities and morphologic changes of 
pulmonary emphysema, such as a decreased FEV, 
and destruction of lung parenchyma. This may be 
indirect evidence of the effects of the loss of lung 
recoil on BHR. 
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